Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Non-Current Assets (2023 - 2025)

Bioharvest Sciences has reported Non-Current Assets over the past 3 years, most recently at $17.2 million for Q4 2025.

  • For Q4 2025, Non-Current Assets changed 0.12% year-over-year to $17.2 million; the TTM value through Dec 2025 reached $17.2 million, changed 0.12%, while the annual FY2025 figure was $17.2 million, 0.12% changed from the prior year.
  • Non-Current Assets was $17.2 million for Q4 2025 at Bioharvest Sciences, down from $17.3 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $17.8 million in Q3 2024 and bottomed at $5.9 million in Q4 2023.
  • The 3-year median for Non-Current Assets is $17.2 million (2025), against an average of $16.1 million.
  • Year-over-year, Non-Current Assets soared 188.15% in 2024 and then dropped 2.76% in 2025.
  • Over 3 years, Non-Current Assets stood at $5.9 million in 2023, then soared by 188.15% to $17.1 million in 2024, then grew by 0.12% to $17.2 million in 2025.
  • The last three reported values for Non-Current Assets were $17.2 million (Q4 2025), $17.3 million (Q3 2025), and $17.5 million (Q2 2025) per Business Quant data.